Literature DB >> 32547227

Mechanism of the Regulatory Effect of Overexpression of circMTO1 on Proliferation and Apoptosis of Hepatoma Cells via miR-9-5p/NOX4 Axis.

Jinbao Wang1, Qingjuan Tan2, Weishan Wang1, Jie Yu3.   

Abstract

PURPOSE: To investigate the potential role of the circMTO1/miR-9-5p/NOX4 axis in liver cancer.
MATERIALS AND METHODS: Human genome-wide circrna microarray V2 was used for analyzing the expression profile of circRNAs in human tissue samples. The TargetScan database was used to predict target genes. Gene overexpression and silencing in hepatoma cell lines were achieved by transfecting the cells with suitable constructs. Quantitative real time PCR and Western blotting were used to analyze gene and protein expression levels. CCK-8 analysis was performed to detect cell proliferation and the transwell assay for analyzing cell migration. Annexin V-FITC/PI staining and immunohistochemistry were respectively used to detect apoptosis and protein expression.
RESULTS: CircMTO1 were down-regulated in the liver cancer tissues and cell lines compared to their respective normal controls. TargetScan database screening and dual luciferase assay revealed that circMTO1 was a molecular sponge of miR-9-5p, and NOX4 was the target gene of miR-9-5p. Overexpression of circMTO1 and NOX4 inhibited proliferation and migration of hepatoma cells, while the overexpression of miR-9-5p had the opposite effects. In contrast, overexpression of circMTO1 and NOX4 promoted apoptosis, while that of miR-9-5p decreased the cell apoptosis rates.
CONCLUSION: Overexpression of CircMTO1 acts as tumor suppressor in liver cancer by sponging miR-9-5p, which upregulates NOX4.
© 2020 Wang et al.

Entities:  

Keywords:  apoptosis; circMTO1; hepatocellular carcinoma; miR-9-5p/NOX4 axis; proliferation

Year:  2020        PMID: 32547227      PMCID: PMC7263879          DOI: 10.2147/CMAR.S240719

Source DB:  PubMed          Journal:  Cancer Manag Res        ISSN: 1179-1322            Impact factor:   3.989


  30 in total

Review 1.  microRNAs: fad or future of liver disease.

Authors:  Ashley M Lakner; Herbert L Bonkovsky; Laura W Schrum
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression.

Authors:  Eva Crosas-Molist; Esther Bertran; Patricia Sancho; Judit López-Luque; Joan Fernando; Aránzazu Sánchez; Margarita Fernández; Estanis Navarro; Isabel Fabregat
Journal:  Free Radic Biol Med       Date:  2014-02-06       Impact factor: 7.376

Review 3.  MicroRNAs in bone development and their diagnostic and therapeutic potentials in osteoporosis.

Authors:  Supaporn Suttamanatwong
Journal:  Connect Tissue Res       Date:  2016-03-10       Impact factor: 3.417

4.  Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection.

Authors:  Nabora Soledad Reyes de Mochel; Scott Seronello; Shelley Hsiuying Wang; Chieri Ito; Jasper Xi Zheng; T Jake Liang; J David Lambeth; Jinah Choi
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

Review 5.  Nox proteins in signal transduction.

Authors:  David I Brown; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2009-07-21       Impact factor: 7.376

6.  Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity.

Authors:  Irene Carmona-Cuenca; César Roncero; Patricia Sancho; Laia Caja; Nelson Fausto; Margarita Fernández; Isabel Fabregat
Journal:  J Hepatol       Date:  2008-09-19       Impact factor: 25.083

7.  Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity.

Authors:  Xintian You; Irena Vlatkovic; Ana Babic; Tristan Will; Irina Epstein; Georgi Tushev; Güney Akbalik; Mantian Wang; Caspar Glock; Claudia Quedenau; Xi Wang; Jingyi Hou; Hongyu Liu; Wei Sun; Sivakumar Sambandan; Tao Chen; Erin M Schuman; Wei Chen
Journal:  Nat Neurosci       Date:  2015-02-25       Impact factor: 24.884

Review 8.  Role of NADPH oxidases in the redox biology of liver fibrosis.

Authors:  Eva Crosas-Molist; Isabel Fabregat
Journal:  Redox Biol       Date:  2015-07-14       Impact factor: 11.799

9.  A high-throughput 3' UTR reporter screening identifies microRNA interactomes of cancer genes.

Authors:  Gert Van Peer; Evelien Mets; Shana Claeys; Ines De Punt; Steve Lefever; Maté Ongenaert; Pieter Rondou; Frank Speleman; Pieter Mestdagh; Jo Vandesompele
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

10.  Identification and characterization of circRNAs as competing endogenous RNAs for miRNA-mRNA in colorectal cancer.

Authors:  Wenliang Yuan; Sihua Peng; Jingyu Wang; Cai Wei; Zhen Ye; Ye Wang; Meiliang Wang; Hao Xu; Shouwen Jiang; Dan Sun; Chaoxu Dai; Linhua Jiang; Xiaobo Li
Journal:  PeerJ       Date:  2019-09-19       Impact factor: 2.984

View more
  3 in total

1.  CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.

Authors:  Dandan Li; Jiawei Zhang; Jing Yang; Jie Wang; Runling Zhang; Jinming Li; Rui Zhang
Journal:  Cell Death Dis       Date:  2021-12-20       Impact factor: 8.469

Review 2.  The Roles of circMTO1 in Cancer.

Authors:  Wei Liu; Yuanyuan Xiong; Renhua Wan; Renfeng Shan; Jianfeng Li; Wu Wen
Journal:  Front Cell Dev Biol       Date:  2021-06-30

Review 3.  CircRNAs: a new target for the diagnosis and treatment of digestive system neoplasms.

Authors:  Jie Li; Qiang Xu; Zi-Jian Huang; Ning Mao; Zhi-Tao Lin; Long Cheng; Bei Sun; Gang Wang
Journal:  Cell Death Dis       Date:  2021-02-24       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.